NIVO/IPI Combo Demonstrates Long-Term Efficacy in NSCLC NIVO/IPI Combo Demonstrates Long-Term Efficacy in NSCLC

After 6 years, previous tumor response, tumor burden reduction, and baseline health-related quality of life all correlated with overall survival.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news